Share:
Peer-Reviewed Publication
NPJ Digit Med2026;9(1)August 13, 2026Letter

Context-aware monitoring: rethinking comprehensive screening in the era of AI.

David A Shaywitz1, Nathan D Price2,3, Daniel K Sodickson4,5
1Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. david_shaywitz@hms.harvard.edu.
2Buck Institute for Research on Aging, Novato, CA, USA.
3Thorne HealthTech, New York, NY, USA.
4Center for Advanced Imaging Innovation and Research (CAI2R), Department of Radiology, New York University Grossman School of Medicine, New York, NY, USA.
5Function Health, Austin, TX, USA.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.